- Home
- XERS vs ASTH Comparison
XERS vs ASTH Comparison
Compare XERS & ASTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XERS
- ASTH
- Stock Information
- Founded
- XERS 2005
- ASTH 1994
- Country
- XERS United States
- ASTH United States
- Employees
- XERS N/A
- ASTH N/A
- Industry
- XERS Biotechnology: Pharmaceutical Preparations
- ASTH Professional Services
- Sector
- XERS Health Care
- ASTH Consumer Discretionary
- Exchange
- XERS Nasdaq
- ASTH Nasdaq
- Market Cap
- XERS 1.3B
- ASTH 1.4B
- IPO Year
- XERS 2018
- ASTH N/A
- Fundamental
- Price
- XERS $7.36
- ASTH $29.19
- Analyst Decision
- XERS Strong Buy
- ASTH Strong Buy
- Analyst Count
- XERS 7
- ASTH 8
- Target Price
- XERS $8.00
- ASTH $53.29
- AVG Volume (30 Days)
- XERS 1.9M
- ASTH 333.5K
- Earning Date
- XERS 11-07-2025
- ASTH 11-06-2025
- Dividend Yield
- XERS N/A
- ASTH N/A
- EPS Growth
- XERS N/A
- ASTH N/A
- EPS
- XERS N/A
- ASTH 0.52
- Revenue
- XERS $246,025,000.00
- ASTH $2,419,115,000.00
- Revenue This Year
- XERS $43.89
- ASTH $60.77
- Revenue Next Year
- XERS $20.40
- ASTH $26.90
- P/E Ratio
- XERS N/A
- ASTH $55.81
- Revenue Growth
- XERS 35.62
- ASTH 51.97
- 52 Week Low
- XERS $2.69
- ASTH $21.20
- 52 Week High
- XERS $8.03
- ASTH $63.20
- Technical
- Relative Strength Index (RSI)
- XERS 51.35
- ASTH 50.31
- Support Level
- XERS $7.56
- ASTH $28.48
- Resistance Level
- XERS $7.89
- ASTH $30.55
- Average True Range (ATR)
- XERS 0.24
- ASTH 1.09
- MACD
- XERS -0.14
- ASTH -0.37
- Stochastic Oscillator
- XERS 2.90
- ASTH 19.29
About XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).
About ASTH Astrana Health Inc. Common Stock
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.